Trial Profile
A study evaluating length of Buprenorphine treatment (LOT) in opioid dependence.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 09 Jun 2016 New trial record
- 25 May 2016 Results (analysis of resource use and costs) presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research